Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2005

Open Access 01-12-2005 | Research

Dobutamine stress echocardiography in healthy adult male rats

Authors: Eric Plante, Dominic Lachance, Marie-Claude Drolet, Élise Roussel, Jacques Couet, Marie Arsenault

Published in: Cardiovascular Ultrasound | Issue 1/2005

Login to get access

Abstract

Background

Dobutamine stress echocardiography is used to investigate a wide variety of heart diseases in humans. Dobutamine stress echocardiography has also been used in animal models of heart disease despite the facts that the normal response of healthy rat hearts to this type of pharmacological stress testing is unknown. This study was performed to assess this normal response.

Methods

15 normal adult male Wistar rats were evaluated. Increasing doses of dobutamine were infused intravenously under continuous imaging of the heart by a 12 MHz ultrasound probe.

Results

Dobutamine stress echocardiography reduced gradually LV diastolic and systolic dimensions. Ejection fraction increased by a mean of +24% vs. baseline. Heart rate increased progressively without reaching a plateau. Changes in LV dimensions and ejection fraction reached a plateau after a mean of 4 minutes at a constant infusion rate.

Conclusion

DSE can be easily performed in rats. The normal response is an increase in heart rate and ejection fraction and a decrease in LV dimensions. A plateau in echocardiographic measurements is obtained after 4 minutes of a constant infusion rate in most animals.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lualdi JC, Douglas PS: Echocardiography for the assessment of myocardial viability. J Am Soc Echocardiogr 1997, 10: 772-780.CrossRefPubMed Lualdi JC, Douglas PS: Echocardiography for the assessment of myocardial viability. J Am Soc Echocardiogr 1997, 10: 772-780.CrossRefPubMed
2.
go back to reference Krahwinkel W, Ketteler T, Godke J, Wolfertz J, Ulbricht LJ, Krakau I, Gulker H: Dobutamine stress echocardiography. Eur Heart J 1997,18(Suppl D):D9-15.CrossRefPubMed Krahwinkel W, Ketteler T, Godke J, Wolfertz J, Ulbricht LJ, Krakau I, Gulker H: Dobutamine stress echocardiography. Eur Heart J 1997,18(Suppl D):D9-15.CrossRefPubMed
3.
go back to reference Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ: Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 1995, 70: 16-27.CrossRefPubMed Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ: Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 1995, 70: 16-27.CrossRefPubMed
4.
go back to reference Krenning BJ, Geleijnse ML, Poldermans D, Roelandt JR: Methodological analysis of diagnostic dobutamine stress echocardiography studies. Echocardiography 2004, 21: 725-736. 10.1111/j.0742-2822.2004.03161.xCrossRefPubMed Krenning BJ, Geleijnse ML, Poldermans D, Roelandt JR: Methodological analysis of diagnostic dobutamine stress echocardiography studies. Echocardiography 2004, 21: 725-736. 10.1111/j.0742-2822.2004.03161.xCrossRefPubMed
5.
go back to reference Wu WC, Bhavsar JH, Aziz GF, Sadaniantz A: An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy. Echocardiography 2004, 21: 467-475. 10.1111/j.0742-2822.2004.03083.xCrossRefPubMed Wu WC, Bhavsar JH, Aziz GF, Sadaniantz A: An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy. Echocardiography 2004, 21: 467-475. 10.1111/j.0742-2822.2004.03083.xCrossRefPubMed
6.
go back to reference Wu WC, Ireland LA, Sadaniantz A: Evaluation of aortic valve disorders using stress echocardiography. Echocardiography 2004, 21: 459-466. 10.1111/j.0742-2822.2004.t01-1-03082.xCrossRefPubMed Wu WC, Ireland LA, Sadaniantz A: Evaluation of aortic valve disorders using stress echocardiography. Echocardiography 2004, 21: 459-466. 10.1111/j.0742-2822.2004.t01-1-03082.xCrossRefPubMed
7.
go back to reference Wu WC, Aziz GF, Sadaniantz A: The use of stress echocardiography in the assessment of mitral valvular disease. Echocardiography 2004, 21: 451-458. 10.1111/j.0742-2822.2004.03081.xCrossRefPubMed Wu WC, Aziz GF, Sadaniantz A: The use of stress echocardiography in the assessment of mitral valvular disease. Echocardiography 2004, 21: 451-458. 10.1111/j.0742-2822.2004.03081.xCrossRefPubMed
8.
go back to reference Picano E: Stress echocardiography. Expert Rev Cardiovasc Ther 2004, 2: 77-88. 10.1586/14779072.2.1.77CrossRefPubMed Picano E: Stress echocardiography. Expert Rev Cardiovasc Ther 2004, 2: 77-88. 10.1586/14779072.2.1.77CrossRefPubMed
9.
go back to reference Sullebarger JT, D'Ambra PM, Clark LC, Thanikarry L, Fontanet HL: Effect of Digoxin on Ventricular Remodeling and Responsiveness of beta-Adrenoceptors in Chronic Volume Overload. J Cardiovasc Pharmacol Ther 1998, 3: 281-290.CrossRefPubMed Sullebarger JT, D'Ambra PM, Clark LC, Thanikarry L, Fontanet HL: Effect of Digoxin on Ventricular Remodeling and Responsiveness of beta-Adrenoceptors in Chronic Volume Overload. J Cardiovasc Pharmacol Ther 1998, 3: 281-290.CrossRefPubMed
10.
go back to reference Croteau E, Benard F, Bentourkia M, Rousseau J, Paquette M, Lecomte R: Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents. J Nucl Med 2004, 45: 1924-1930.PubMed Croteau E, Benard F, Bentourkia M, Rousseau J, Paquette M, Lecomte R: Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents. J Nucl Med 2004, 45: 1924-1930.PubMed
11.
go back to reference Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr., Ribeiro LG, Miller RR: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981, 64: 744-53.CrossRefPubMed Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr., Ribeiro LG, Miller RR: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981, 64: 744-53.CrossRefPubMed
12.
go back to reference McFalls EO, Murad B, Haspel HC, Marx D, Sikora J, Ward HB: Myocardial glucose uptake after dobutamine stress in chronic hibernating swine myocardium. J Nucl Cardiol 2003, 10: 385-394. 10.1016/S1071-3581(03)00431-8CrossRefPubMed McFalls EO, Murad B, Haspel HC, Marx D, Sikora J, Ward HB: Myocardial glucose uptake after dobutamine stress in chronic hibernating swine myocardium. J Nucl Cardiol 2003, 10: 385-394. 10.1016/S1071-3581(03)00431-8CrossRefPubMed
13.
go back to reference Handke M, Heinrichs G, Magosaki E, Lutter G, Bode C, Geibel A: Three-dimensional echocardiographic determination of cardiac output at rest and under dobutamine stress: comparison with thermodilution measurements in the ischemic pig model. Echocardiography 2003, 20: 47-55. 10.1046/j.1540-8175.2003.00006.xCrossRefPubMed Handke M, Heinrichs G, Magosaki E, Lutter G, Bode C, Geibel A: Three-dimensional echocardiographic determination of cardiac output at rest and under dobutamine stress: comparison with thermodilution measurements in the ischemic pig model. Echocardiography 2003, 20: 47-55. 10.1046/j.1540-8175.2003.00006.xCrossRefPubMed
14.
go back to reference Weidemann F, Dommke C, Bijnens B, Claus P, D'hooge J, Mertens P, Verbeken E, Maes A, Van de WF, De SI, et al.: Defining the transmurality of a chronic myocardial infarction by ultrasonic strain-rate imaging: implications for identifying intramural viability: an experimental study. Circulation 2003, 107: 883-888. 10.1161/01.CIR.0000050146.66577.4BCrossRefPubMed Weidemann F, Dommke C, Bijnens B, Claus P, D'hooge J, Mertens P, Verbeken E, Maes A, Van de WF, De SI, et al.: Defining the transmurality of a chronic myocardial infarction by ultrasonic strain-rate imaging: implications for identifying intramural viability: an experimental study. Circulation 2003, 107: 883-888. 10.1161/01.CIR.0000050146.66577.4BCrossRefPubMed
15.
go back to reference Hammond HK, McKirnan MD: Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. J Am Coll Cardiol 1994, 23: 475-482.CrossRefPubMed Hammond HK, McKirnan MD: Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. J Am Coll Cardiol 1994, 23: 475-482.CrossRefPubMed
16.
go back to reference Bin JP, Le DE, Jayaweera AR, Coggins MP, Wei K, Kaul S: Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography. J Am Soc Echocardiogr 2003, 16: 871-879. 10.1067/S0894-7317(03)00423-1CrossRefPubMed Bin JP, Le DE, Jayaweera AR, Coggins MP, Wei K, Kaul S: Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography. J Am Soc Echocardiogr 2003, 16: 871-879. 10.1067/S0894-7317(03)00423-1CrossRefPubMed
17.
go back to reference Le DE, Bin JP, Coggins MP, Wei K, Lindner JR, Kaul S: Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. J Am Soc Echocardiogr 2002, 15: 857-863. 10.1067/mje.2002.121275CrossRefPubMed Le DE, Bin JP, Coggins MP, Wei K, Lindner JR, Kaul S: Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. J Am Soc Echocardiogr 2002, 15: 857-863. 10.1067/mje.2002.121275CrossRefPubMed
18.
go back to reference McEntee K, Amory H, Clercx C, Soyeur D, Michaux C, Vanhaeverbeek O, Jacqmot O, Henroteaux M: Physiologic response to dobutamine infusion during cardiac stress testing of dogs. Am J Vet Res 1998, 59: 1160-1165.PubMed McEntee K, Amory H, Clercx C, Soyeur D, Michaux C, Vanhaeverbeek O, Jacqmot O, Henroteaux M: Physiologic response to dobutamine infusion during cardiac stress testing of dogs. Am J Vet Res 1998, 59: 1160-1165.PubMed
19.
go back to reference Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y, Date MO, Chrast J, Matsuzaki M, Peterson KL, et al.: Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 2004, 113: 727-736. 10.1172/JCI200418716CrossRefPubMedPubMedCentral Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y, Date MO, Chrast J, Matsuzaki M, Peterson KL, et al.: Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 2004, 113: 727-736. 10.1172/JCI200418716CrossRefPubMedPubMedCentral
20.
go back to reference Sun LS, Takuma S, Lui R, Homma S: The effect of maternal cocaine exposure on neonatal rat cardiac function. Anesth Analg 2003, 97: 878-882. 10.1213/01.ANE.0000074792.87311.DBCrossRefPubMed Sun LS, Takuma S, Lui R, Homma S: The effect of maternal cocaine exposure on neonatal rat cardiac function. Anesth Analg 2003, 97: 878-882. 10.1213/01.ANE.0000074792.87311.DBCrossRefPubMed
21.
go back to reference Abraham TP, Laskowski C, Zhan WZ, Belohlavek M, Martin EA, Greenleaf JF, Sieck GC: Myocardial contractility by strain echocardiography: comparison with physiological measurements in an in vitro model. Am J Physiol Heart Circ Physiol 2003, 285: H2599-H2604.CrossRefPubMed Abraham TP, Laskowski C, Zhan WZ, Belohlavek M, Martin EA, Greenleaf JF, Sieck GC: Myocardial contractility by strain echocardiography: comparison with physiological measurements in an in vitro model. Am J Physiol Heart Circ Physiol 2003, 285: H2599-H2604.CrossRefPubMed
22.
go back to reference Southworth R, Garlick PB: Dobutamine responsiveness, PET mismatch, and lack of necrosis in low-flow ischemia: is this hibernation in the isolated rat heart? Am J Physiol Heart Circ Physiol 2003, 285: H316-H324.CrossRefPubMed Southworth R, Garlick PB: Dobutamine responsiveness, PET mismatch, and lack of necrosis in low-flow ischemia: is this hibernation in the isolated rat heart? Am J Physiol Heart Circ Physiol 2003, 285: H316-H324.CrossRefPubMed
23.
go back to reference Sullebarger JT, D'Ambra PM, Clark LC, Thanikarry L, Fontanet HL: Effect of Digoxin on Ventricular Remodeling and Responsiveness of beta-Adrenoceptors in Chronic Volume Overload. J Cardiovasc Pharmacol Ther 1998, 3: 281-290.CrossRefPubMed Sullebarger JT, D'Ambra PM, Clark LC, Thanikarry L, Fontanet HL: Effect of Digoxin on Ventricular Remodeling and Responsiveness of beta-Adrenoceptors in Chronic Volume Overload. J Cardiovasc Pharmacol Ther 1998, 3: 281-290.CrossRefPubMed
24.
go back to reference Krenz M, Robbins J: Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol 2004, 44: 2390-2397. 10.1016/j.jacc.2004.09.044CrossRefPubMed Krenz M, Robbins J: Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol 2004, 44: 2390-2397. 10.1016/j.jacc.2004.09.044CrossRefPubMed
25.
go back to reference Broberg CS, Pantely GA, Barber BJ, Mack GK, Lee K, Thigpen T, Davis LE, Sahn D, Hohimer AR: Validation of the myocardial performance index by echocardiography in mice: a noninvasive measure of left ventricular function. J Am Soc Echocardiogr 2003, 16: 814-823. 10.1067/S0894-7317(03)00399-7CrossRefPubMed Broberg CS, Pantely GA, Barber BJ, Mack GK, Lee K, Thigpen T, Davis LE, Sahn D, Hohimer AR: Validation of the myocardial performance index by echocardiography in mice: a noninvasive measure of left ventricular function. J Am Soc Echocardiogr 2003, 16: 814-823. 10.1067/S0894-7317(03)00399-7CrossRefPubMed
26.
go back to reference Nemoto S, DeFreitas G, Mann DL, Carabello BA: Effects of changes in left ventricular contractility on indexes of contractility in mice. Am J Physiol Heart Circ Physiol 2002, 283: H2504-H2510.CrossRefPubMed Nemoto S, DeFreitas G, Mann DL, Carabello BA: Effects of changes in left ventricular contractility on indexes of contractility in mice. Am J Physiol Heart Circ Physiol 2002, 283: H2504-H2510.CrossRefPubMed
27.
go back to reference Williams RV, Lorenz JN, Witt SA, Hellard DT, Khoury PR, Kimball TR: End-systolic stress-velocity and pressure-dimension relationships by transthoracic echocardiography in mice. Am J Physiol 1998, 274: H1828-H1835.PubMed Williams RV, Lorenz JN, Witt SA, Hellard DT, Khoury PR, Kimball TR: End-systolic stress-velocity and pressure-dimension relationships by transthoracic echocardiography in mice. Am J Physiol 1998, 274: H1828-H1835.PubMed
28.
go back to reference Hoit BD, Khan ZU, Pawloski-Dahm CM, Walsh RA: In vivo determination of left ventricular wall stress-shortening relationship in normal mice. Am J Physiol 1997, 272: H1047-H1052.PubMed Hoit BD, Khan ZU, Pawloski-Dahm CM, Walsh RA: In vivo determination of left ventricular wall stress-shortening relationship in normal mice. Am J Physiol 1997, 272: H1047-H1052.PubMed
29.
go back to reference Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross J Jr: Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 1996, 94: 1109-1117.CrossRefPubMed Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross J Jr: Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 1996, 94: 1109-1117.CrossRefPubMed
Metadata
Title
Dobutamine stress echocardiography in healthy adult male rats
Authors
Eric Plante
Dominic Lachance
Marie-Claude Drolet
Élise Roussel
Jacques Couet
Marie Arsenault
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2005
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-3-34

Other articles of this Issue 1/2005

Cardiovascular Ultrasound 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.